An important milestone has been reached for the GNA NOW Consortium, which BIOASTER is proud to be a partner of. A Go-decision has been received for the project’s NOSO-502 program to continue preparations for the first-in-human Phase 1 clinical study! This decision demonstrates the quality and innovativeness of NOSO-502, which...

BIOASTER was invited by the Bill & Melinda Gates foundation to present progress of its granted projects on rapid test for infectious diseases in LMIC....